GILEAD SCIENCES, INC.
Portfolio value QoQ: -22.1% 13F does not disclose cash
Top 10 holdings weight100.00%
Top 25 holdings weight100.00%
Positions above 1%4
Effective number of positions2.2
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.69% Est. buys $12,962,261 · sells $771,682,600
Median holding: 3.0 quarters Tracked Q1 2025–Q2 2026 · 35.7% still held
New positions0
Increased1
Decreased0
Closed1
Portfolio value
$1.6B
Positions
5
As of
June 30, 2026 Data as of Q2 2026
Sector breakdown
Full portfolio 5 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| RCUS | $968,825,351 | 58.76% | 31,424,760 | $290,050,535 | |||
| GLPG | $500,157,715 | 30.34% | 16,707,477 | $-1,066,595 | |||
| ASMB | $136,770,406 | 8.30% | 4,977,089 | $11,745,806 | Up ×1 | ||
| KYTX | $36,763,720 | 2.23% | 4,126,119 | $1,155,313 | |||
| XLO | $6,230,727 | 0.38% | 650,389 | $760,956 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| ACLX | June 30, 2026 | 6,720,803 | $771,682,600 | No longer tracked |
| MRUS | Dec. 31, 2025 | 452,527 | $42,605,417 | No longer tracked |
| TNGX | Dec. 31, 2025 | 4,854,443 | $40,777,321 | 162.3% |
| CYPH | Dec. 31, 2025 | 5,319,148 | $2,414,893 | 161.2% |
| HOOK | Sept. 30, 2025 | 1,875,945 | $2,354,311 | No longer tracked |
| ALLO | Sept. 30, 2025 | 1,156,689 | $1,307,059 | 21.0% |
| KLRS | Sept. 30, 2025 | 317,789 | $848,497 | -53.3% |
| IKNA | Sept. 30, 2025 | 348,534 | $467,053 | No longer tracked |
| BRNS | Sept. 30, 2025 | 99,478 | $92,524 | No longer tracked |